On 2025-05-14, LAVA Therapeutics N.V. (LVTX) announced earnings per share of $-0.13 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.37.
The next expected annoucement date for quarterly earnings is 2025-08-19, with an average estimated earnings per share of $-0.28 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-14 | 2025-03-31 | $-0.37 | $-0.13 |
| 2025-03-28 | 2024-12-31 | $-0.26 | $-0.14 |
| 2024-12-10 | 2024-09-30 | $-0.35 | $-0.46 |
| 2024-08-20 | 2024-06-30 | $-0.33 | $-0.31 |
| 2024-05-21 | 2024-03-31 | $-0.25 | $-0.02 |
| 2024-03-20 | 2023-12-31 | $0.16 | $-0.24 |
| 2023-11-16 | 2023-09-30 | $-0.48 | $-0.34 |
| 2023-08-22 | 2023-06-30 | $-0.48 | $-0.48 |
| 2023-06-08 | 2023-03-31 | $-0.47 | $-0.53 |
| 2023-04-11 | 2022-12-31 | -- | $-0.57 |
| 2022-11-16 | 2022-09-30 | $-0.07 | $0.04 |
| 2022-09-13 | 2022-06-30 | $-0.61 | $-0.31 |
| 2022-05-17 | 2022-03-31 | $-0.95 | $-0.41 |
| 2022-03-24 | 2021-12-31 | $-0.38 | $-0.38 |
| 2021-11-15 | 2021-09-30 | $-0.33 | $-0.27 |
| 2021-08-16 | 2021-06-30 | $-0.31 | $-0.28 |
| 2021-05-20 | 2021-03-31 | $-0.27 | $-12.28 |